Price Chart

Executive Summary

BioCryst held its 2026 Annual Meeting on June 11, 2026, where shareholders approved an amendment to the Stock Incentive Plan to increase shares available by 7 million, ratified Ernst & Young as auditor, and elected three directors. The plan amendment passed with 119.8 million votes for and 63.3 million against (65.4% approval of votes cast). This is a routine governance event with no material financial impact, as the additional shares simply replenish the equity compensation pool for future awards to employees and directors.

Key Facts

• Shareholders approved an amendment to the Stock Incentive Plan to increase the number of shares available for issuance by 7,000,000 shares.
• Total shares available under the Plan as of April 20, 2026, was 61,000,333 (including 46,287,133 already issued, 7,713,200 available, and the 7,000,000 increase).
• Maximum shares issuable over the Plan's term is 88,090,000.
• The Plan includes a 12-month minimum vesting period for awards (with exceptions for death, disability, or change in control, and for up to 5% of shares).
• Each non-employee director is subject to an annual compensation cap of $750,000 ($1,000,000 for first-year directors).
• The three director nominees (Theresa M. Heggie, Amy E. McKee, Jon P. Stonehouse) were elected with strong support (96-98% of votes cast in favor, excluding broker non-votes).
• Ratification of Ernst & Young as independent auditor passed with 96.5% of votes cast in favor.
• Advisory vote on executive compensation passed with 68.9% of votes cast in favor, though with significant opposition (31.1% against).

Financial Impact

No direct financial impact. The 7 million-share increase (approximately 3.2% of shares outstanding at current share count, assuming ~217M shares outstanding) expands the equity pool for future compensation grants but does not represent immediate dilution or cash cost.

Risk Factors

• The Incentive Plan Proposal received 34.6% of votes cast against, indicating notable opposition from some shareholders.
• Increased equity compensation could gradually dilute existing shareholders if large grants are made under the replenished share pool.
• Advisory say-on-pay vote of 68.9% is below 70% threshold that some governance watchdogs consider a red flag, though not material.
• Broker non-votes of 34 million (approx. 18% of outstanding) on the incentive plan and say-on-pay reflect passive institutional block.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

US Market Status